HPV and cervical cancer: screening or vaccination?

Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary effo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, F X, Castellsagué, X, de Sanjosé, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359713/
https://www.ncbi.nlm.nih.gov/pubmed/18182975
http://dx.doi.org/10.1038/sj.bjc.6604146
Descripción
Sumario:Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition.

Ejemplares similares